Loomis Sayles & CO L P Verona Pharma PLC Transaction History
Loomis Sayles & CO L P
- $76.2 Billion
- Q3 2024
A detailed history of Loomis Sayles & CO L P transactions in Verona Pharma PLC stock. As of the latest transaction made, Loomis Sayles & CO L P holds 1,111,096 shares of VRNA stock, worth $50.3 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,111,096Holding current value
$50.3 Million% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
167Shares Held
68.7MCall Options Held
704KPut Options Held
685K-
Perceptive Advisors LLC New York, NY6.32MShares$286 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$253 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$227 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$191 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$161 Million14.95% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.76B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...